Publication at First Faculty of Medicine |
2017
Abstract
Cardiovascular diseases are an increasingly common cause of death, primarily in industrialised countries, such as the Czech Republic. The most important step towards lowering cardiovasular morbidity and mortality is mitigating the risk factors.
This represents a generally accepted trend in prevention and treatment of cardiovascular disease. Pharmacotheprapy of hyperlipoproteinemia and dyslipidemia is considered to be one of the most efficient preventive and therapeutic procedures.